Skip to main content

VitaNova Life Sciences Corp

corporate_fare Company Profile

VitaNova Life Sciences Corp

VNOV·OTC·Trade & Services·CIK 0001699709

YIJIA GROUP CORP. is a U.S.-focused consumer health, beauty, and lifestyle company that develops, acquires, markets, and sells branded nutritional supplements, functional beverages, and complementary lifestyle products. Its dietary supplement operations are consolidated and commercialized through NutriPeak Trading Corporation ("NTC"), a wholly owned subsidiary formed in November 2023. Since November 2023, substantially all of the Company's operations have been conducted through NTC. NTC develops two product lines: an advanced, science-oriented line for general cellular and cognitive wellness, and a mass market line for high-velocity e-commerce and marketplace channels. The Company operates with an asset-light model, handling product strategy, formulation oversight, brand management, and regulatory compliance internally, while using third-party contract manufacturers and logistics partners for production, packaging, and fulfillment. YIJIA GROUP CORP. primarily uses a Business-to-Business (B2B) commercial model, partnering with regional distributors and channel partners. These partners utilize diversified online traffic channels, including Douyin Cross-border, Weidian Cross-border, and direct-to-consumer sales in the United States, to drive sales. Starting July 30, 2021, the Company also began providing business consulting services to domestic and international customers, focusing on funding and financial matters. During the year ended April 30, 2026, the Company launched a new product line selling healthy food products such as olive juice, white sesame oil, and aloe vera drink. The Company was incorporated on January 25, 2017, in Nevada, initially as Soldino Group Corp., and changed its name to Yijia Group Corp. on November 15, 2018.

VitaNova Life Sciences Corp (OTC:VNOV) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 3 items for VNOV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-14, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above. Recent SEC coverage for VNOV spans 10-Q, 10-K.

Recent high-impact activity:

  • VitaNova Q1 Loss Widens 166% as Gross Margin Collapses to 9%
  • VitaNova 10-K Exposes Material Weaknesses, Governance Gaps, and Margin Compression Despite Revenue Growth
  • VitaNova Reports Q3 Loss, Strong Revenue Growth, and Material Weaknesses in Internal Controls

Financial Snapshot

Fiscal year ended April 30, 2025
Revenue
$2.66M
Net Income
$850.75K
Diluted EPS
$0.03
Op. Cash Flow
$192.77K
Gross Profit
$1.58M
Operating Income
$1.21M
Cash & Equivalents
$782.81K
Debt / Equity
0.00×
Net Margin
32.0%
Shares Outstanding
25.01M sh
Source: 10-K · filed 2025-07-24 · accession 0001683168-25-005368

Short Interest & Short Volume

FINRA reported short interest of 33 shares in VNOV as of the September 15, 2026 settlement, unchanged from the prior period.

Short interest (bi-monthly positions)33 shares as of September 15, 2026
Change vs prior period 0.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with V →
$2.38
52-week range · as of 2026-09-14 $1.27 – $45
Market cap
$19.84M
Volume
100 (0.3× avg)
3-mo avg 287.3
Last traded · 2026-08-03

show_chartPrice Chart

Loading chart...

feed VNOV - Latest Insights

VNOV
Sep 14, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.38
Real-time Price: $2.38 info
Change: $0 (0%) info
Market Cap: $19.843M info
VNOV
Jul 29, 2026, 5:02 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $2.38
Real-time Price: $2.38 info
Change: $0 (0%) info
Market Cap: $19.843M info
VNOV
Mar 16, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.83
Real-time Price: $2.38 info
Change: -$2.45 (-51%) info
Market Cap: $19.843M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets